Active-ingredient Dossier
Ramipril
Active-ingredient Dossier for Ramipril (angiotensin converting enzyme inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: RAMIPRIL
- Brand: TRITACE
- Brand: TRYZAN
- Brand: PRILACE
- Brand: APO-RAMIPRIL
- Brand: APX-RAMIPRIL
- Therapeutic area: Cardiology
What is
Ramipril Ramipril is an angiotensin converting enzyme inhibitor.
Australian brands containing
Ramipril — RAMIPRIL — TRITACE — TRYZAN — PRILACE — APO-RAMIPRIL — APX-RAMIPRIL — RAMIPRIL SANDOZ — RAMIPRIL TABS-WGR — RAMIPRIL VIATRIS — RAMIPRIL-WGR — TRIASYN
Therapeutic areas
Ramipril is registered in neurology (15 brands) and cardiology (2 brands).
Sponsor landscape
The ingredient is marketed by eight sponsors: Arrotex Pharmaceuticals, Sanofi-Aventis, GM Pharma, Lupin, Sandoz, and Helix Pharmaceuticals.
PBS and regulatory activity
Three brands containing ramipril have PBS-listed items. The latest PBS schedule date is 1 May 2026. The latest PBAC outcome on record is 1 March 2007.